An introduction from
our management

- Chairman's Statement

- Letter from the CEO

o1
Chiesi at a Glance

02
Positive Impacts
and Challenges

- Products and Patients
- Processes

- Global Value Chain

- Corporate Citizenship

03

Chiesi’s contribution
to the UN Sustainable
Development Goals

04

Annexes

- Impact Report

- Data, Methodology
and GRI Content Index

Those dimensions also correspond to the 4 specific purposes of common bene-

fit that we have elected since becoming a Benefit Corporation.

We are committed to implementing the necessary actions to reach the objecti-

ves set out in the selected areas. In the following pages, we want to share the

positive effects achieved through the actions implemented and the efforts

put in place by Chiesi at the global level, that go well beyond KPIs and mea-

surable objectives.

1. Products and Patients

 

Associated purpose of common benefit:

Positive effects generated in 2019:

 

 

Improving patients’ and peoples’ lives,
aiming to improve their health, wel-

Ibeing and quality of life.

 

* Improving patients’ health
* Fostering Research & Development
and substantially contributing to

the scientific progress

 

 

2. Processes

 

Associated purpose of common benefit:

Positive effects generated in 2019:

 

 

Continuous innovation towards the
sustainability of processes and all
company practices in order to minimi-
se negative impacts, in favour of po-
sitive ones, on people, the biosphere

and on the territory.

 

* Ensuring regular supply of high quali-
ty medicinal products for the patien-
ts in need

* Lowering our impact on the biosphere

* Fostering the self-fulfilment and wel-
Ibeing of the Chiesi people

* Guaranteeing a safe and healthy

working place for our employees

 

 

32

cts and challenges

ive impa

ti

Posi
